Neuland Laboratories Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | (8.90) | 13.50 | 8.70 | 0.74 |
| Op profit growth | (53) | 32.20 | 20.80 | (5.70) |
| EBIT growth | (63) | 32.80 | 27.60 | (12) |
| Net profit growth | (74) | 71.50 | 71.30 | (41) |
| Profitability ratios (%) | ||||
| OPM | 9.56 | 18.40 | 15.80 | 14.20 |
| EBIT margin | 6.23 | 15.20 | 13 | 11.10 |
| Net profit margin | 2.29 | 8.10 | 5.36 | 3.40 |
| RoCE | 3.81 | 15.10 | 17.60 | 14.80 |
| RoNW | 0.55 | 3.20 | 3.93 | 2.79 |
| RoA | 0.35 | 2 | 1.80 | 1.13 |
| Per share ratios () | ||||
| EPS | 13.50 | 52.30 | 29.80 | 17.50 |
| Dividend per share | -- | -- | 2 | 1.50 |
| Cash EPS | (11) | 30.90 | 12.90 | 0.70 |
| Book value per share | 623 | 609 | 208 | 180 |
| Valuation ratios | ||||
| P/E | 52.50 | 28.40 | 23.50 | 19 |
| P/CEPS | (63) | 48.20 | 54.30 | 477 |
| P/B | 1.13 | 2.44 | 3.37 | 1.85 |
| EV/EBIDTA | 16.90 | 14 | 9.66 | 7.07 |
| Payout (%) | ||||
| Dividend payout | -- | -- | 7.83 | 10 |
| Tax payout | (13) | (30) | (36) | (36) |
| Liquidity ratios | ||||
| Debtor days | 130 | 94.60 | 88.70 | 96.30 |
| Inventory days | 107 | 82.50 | 85.90 | 80.50 |
| Creditor days | (84) | (71) | (87) | (93) |
| Leverage ratios | ||||
| Interest coverage | (1.70) | (4.20) | (2.70) | (1.90) |
| Net debt / equity | 0.54 | 0.33 | 0.92 | 1.12 |
| Net debt / op. profit | 5.99 | 1.69 | 2.14 | 2.71 |
| Cost breakup () | ||||
| Material costs | (45) | (45) | (50) | (52) |
| Employee costs | (20) | (16) | (13) | (11) |
| Other costs | (26) | (20) | (22) | (23) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Revenue | 527 | 579 | 510 | 469 |
| yoy growth (%) | (8.90) | 13.50 | 8.70 | 0.74 |
| Raw materials | (238) | (263) | (253) | (244) |
| As % of sales | 45.20 | 45.40 | 49.70 | 52 |
| Employee costs | (103) | (93) | (65) | (52) |
| As % of sales | 19.50 | 16 | 12.80 | 11 |
| Other costs | (136) | (117) | (111) | (107) |
| As % of sales | 25.70 | 20.20 | 21.70 | 22.80 |
| Operating profit | 50.40 | 106 | 80.40 | 66.60 |
| OPM | 9.56 | 18.40 | 15.80 | 14.20 |
| Depreciation | (22) | (19) | (16) | (15) |
| Interest expense | (19) | (21) | (24) | (27) |
| Other income | 4.53 | 1.17 | 1.78 | 0.78 |
| Profit before tax | 13.90 | 67.20 | 42 | 24.70 |
| Taxes | (1.90) | (20) | (15) | (8.80) |
| Tax rate | (13) | (30) | (36) | (36) |
| Minorities and other | -- | -- | 0.25 | 0.01 |
| Adj. profit | 12.10 | 46.90 | 27.30 | 15.90 |
| Exceptional items | -- | -- | -- | -- |
| Net profit | 12.10 | 46.90 | 27.30 | 15.90 |
| yoy growth (%) | (74) | 71.50 | 71.30 | (41) |
| NPM | 2.29 | 8.10 | 5.36 | 3.40 |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Profit before tax | 13.90 | 67.20 | 42 | 24.70 |
| Depreciation | (22) | (19) | (16) | (15) |
| Tax paid | (1.90) | (20) | (15) | (8.80) |
| Working capital | 187 | 148 | 58.90 | 38.30 |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | 177 | 175 | 70.20 | 38.90 |
| Capital expenditure | 267 | 230 | 41.40 | 5.11 |
| Free cash flow | 444 | 406 | 112 | 44 |
| Equity raised | 609 | 564 | 245 | 255 |
| Investments | 0.51 | 0.49 | 0.03 | 0.03 |
| Debt financing/disposal | 93.80 | (17) | 27.80 | 53.70 |
| Dividends paid | -- | -- | 1.78 | 1.33 |
| Other items | -- | -- | -- | -- |
| Net in cash | 1,147 | 953 | 387 | 354 |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Equity capital | 12.90 | 8.95 | 8.95 | 8.95 |
| Preference capital | -- | -- | -- | -- |
| Reserves | 686 | 549 | 537 | 178 |
| Net worth | 699 | 558 | 546 | 187 |
| Minority interest | ||||
| Debt | 231 | 319 | 192 | 182 |
| Deferred tax liabilities (net) | 80.80 | 64.60 | 45.70 | 19.80 |
| Total liabilities | 1,012 | 942 | 783 | 388 |
| Fixed assets | 646 | 601 | 485 | 179 |
| Intangible assets | ||||
| Investments | 7.90 | 7.90 | 7.88 | 7.39 |
| Deferred tax asset (net) | 69.60 | 51.80 | 30.60 | 5.13 |
| Net working capital | 250 | 264 | 247 | 187 |
| Inventories | 193 | 175 | 135 | 127 |
| Inventory Days | -- | 121 | 85.20 | 90.70 |
| Sundry debtors | 164 | 194 | 181 | 119 |
| Debtor days | -- | 134 | 114 | 85.30 |
| Other current assets | 82 | 76.30 | 63.80 | 81.90 |
| Sundry creditors | (129) | (130) | (89) | (93) |
| Creditor days | -- | 89.90 | 56.40 | 66.70 |
| Other current liabilities | (59) | (52) | (43) | (48) |
| Cash | 37.80 | 17.30 | 12.50 | 9.71 |
| Total assets | 1,012 | 942 | 783 | 388 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Dec-2019 | Sep-2019 | Jun-2019 | Mar-2019 | Dec-2018 |
|---|---|---|---|---|---|
| Gross Sales | 204 | 186 | 181 | 173 | 171 |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 204 | 186 | 181 | 173 | 171 |
| Other Operating Income | -- | -- | -- | -- | -- |
| Other Income | 1.02 | 0.57 | 0.52 | 1.33 | 0.41 |
| Total Income | 205 | 187 | 182 | 174 | 172 |
| Total Expenditure ** | 176 | 161 | 162 | 154 | 156 |
| PBIDT | 29.20 | 25.50 | 19.20 | 19.80 | 16.40 |
| Interest | 5.69 | 4.78 | 4.03 | 4.71 | 3 |
| PBDT | 23.50 | 20.70 | 15.20 | 15.10 | 13.40 |
| Depreciation | 7.82 | 8.28 | 7.55 | 6.93 | 7.35 |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | 3.16 | 3.29 | 1.98 | 2.15 | 1.59 |
| Deferred Tax | 1.40 | 0.47 | (0.10) | (0.60) | (0.30) |
| Reported Profit After Tax | 11.10 | 8.69 | 5.71 | 6.64 | 4.69 |
| Minority Interest After NP | -- | -- | -- | -- | -- |
| Net Profit after Minority Interest | 11.10 | 8.69 | 5.71 | 6.64 | 4.69 |
| Extra-ordinary Items | -- | -- | -- | -- | -- |
| Adjusted Profit After Extra-ordinary item | 11.10 | 8.69 | 5.71 | 6.64 | 4.69 |
| EPS (Unit Curr.) | 8.66 | 6.77 | 4.45 | 5.17 | 3.66 |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 14.30 | 13.70 | 10.60 | 11.50 | 9.55 |
| PBDTM(%) | 11.50 | 11.10 | 8.37 | 8.75 | 7.80 |
| PATM(%) | 5.45 | 4.67 | 3.15 | 3.85 | 2.74 |
